Skip to content
VuFind
  • 0 Items in e-Shelf (Full)
  • History
  • User Account
  • Logout
  • User Account
  • Help
    • English
    • Deutsch
  • Books & more
  • Articles & more
  • JuSER
Advanced
 
  • Literature Request
  • Cite this
  • Email this
  • Export
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
    • Export to MARC
    • Export to MARCXML
    • Export to BibTeX
  • Favorites
  • Add to e-Shelf Remove from e-Shelf


QR Code
This title appears in the Scientific Report : 2015 

Uptake and tracer kinetics of O-(2-18F-fluoroethyl)-l-tyrosine in meningiomas: preliminary results.

Uptake and tracer kinetics of O-(2-18F-fluoroethyl)-l-tyrosine in meningiomas: preliminary results.

PurposeO-(2-[18F]Fluoroethyl)-l-tyrosine (18F-FET) is a well-established PET tracer for the imaging of cerebral gliomas, but little is known about 18F-FET uptake in meningiomas. The aim of this study was to explore 18F-FET kinetics and tumour-to-background contrast in meningiomas of various histolog...

More

Saved in:
Personal Name(s): Cornelius, Jan F. (Corresponding Author)
Stoffels, Gabriele / Filss, Christian / Galldiks, Norbert / Slotty, Philipp / Kamp, Marcel / el Khatib, Mustafa / Hänggi, Daniel / Sabel, Michael / Felsberg, Jörg / Steiger, Hans Jakob / Coenen, Heinrich Hubert / Shah, Nadim J. / Langen, Karl-Josef
Contributing Institute: Kognitive Neurowissenschaften; INM-3
Nuklearchemie; INM-5
Physik der Medizinischen Bildgebung; INM-4
Published in: European journal of nuclear medicine and molecular imaging, 42 (2015) 3, S. 459-467
Imprint: Heidelberg [u.a.] Springer-Verl. 2015
DOI: 10.1007/s00259-014-2934-0
Document Type: Journal Article
Research Program: (Dys-)function and Plasticity
Publikationsportal JuSER
Please use the identifier: http://dx.doi.org/10.1007/s00259-014-2934-0 in citations.

  • Description
  • Staff View
LEADER 07809nam a2201021 a 4500
001 171800
005 20210129214315.0
024 7 |a 10.1007/s00259-014-2934-0  |2 doi 
024 7 |a 0340-6997  |2 ISSN 
024 7 |a 1432-105X  |2 ISSN 
024 7 |a 1619-7070  |2 ISSN 
024 7 |a 1619-7089  |2 ISSN 
024 7 |a WOS:000349368700011  |2 WOS 
037 |a FZJ-2014-05362 
082 |a 610 
100 1 |a Cornelius, Jan F.  |0 P:(DE-HGF)0  |b 0  |e Corresponding Author 
245 |a Uptake and tracer kinetics of O-(2-18F-fluoroethyl)-l-tyrosine in meningiomas: preliminary results. 
260 |a Heidelberg [u.a.]  |c 2015  |b Springer-Verl. 
520 |a PurposeO-(2-[18F]Fluoroethyl)-l-tyrosine (18F-FET) is a well-established PET tracer for the imaging of cerebral gliomas, but little is known about 18F-FET uptake in meningiomas. The aim of this study was to explore 18F-FET kinetics and tumour-to-background contrast in meningiomas of various histologies.MethodsA group of 24 patients with suspected cerebral meningioma on MRI/CT had an additional dynamic 18F-FET PET scan prior to surgery. Time–activity curves (TAC) of 18F-FET uptake in the tumours and tumour-to-brain ratios (TBR) for early (3 – 14 min after injection) and late 18F-FET uptake (20 – 40 min after injection) were analysed and compared with histological subtypes and WHO grade. 18F-FET uptake in critical structures in the skull base was also evaluated in terms of tumour-to-tissue (T/Tis) ratio.ResultsTBR of 18F-FET uptake in meningiomas was significantly higher in the early phase than in the late phase (3.5 ± 0.8 vs. 2.2 ± 0.3; P < 0.001). The difference in TBR between low-grade meningiomas (WHO grade I, 18 patients) and high-grade meningiomas (WHO grade II or III, 6 patients) was significant in the late phase of 18F-FET uptake (2.1 ± 0.2 vs. 2.5 ± 0.2, P = 0.003) while there was no significant difference in the early phase. ROC analysis showed that TBR of 18F-FET uptake in the late phase had significant power to differentiate low-grade from high-grade meningiomas (AUC 0.87 ± 0.18, sensitivity 83 %, specificity 83 %, optimal cut-off 2.3; P < 0.01). Evaluation of TAC yielded three different curve patterns of 18F-FET PET uptake. Combination of TBR (cut-off value 2.3) and TAC pattern slightly improved the differentiation of high-grade from low-grade meningiomas (accuracy 92 %; P = 0.001). Analysis of background radioactivity in the skull base indicated that 18F-FET uptake may be helpful in distinguishing meningioma tissue in the late phase. T/Tis ratios were >1.2 in all patients for the periorbita, sphenoidal sinus, pituitary gland, tentorium, bone and brain, in more than 90 % of patients for the mucosa and dura, but in only 63 % of patients for the cavernous sinus.Conclusion18F-FET PET may provide additional information for noninvasive grading of meningiomas and possibly for the discrimination of tumour in critical areas of the skull base. A further evaluation of 18F-FET PET in meningiomas appears to be justified. 
588 |a Dataset connected to CrossRef, juser.fz-juelich.de 
700 1 |a Stoffels, Gabriele  |0 P:(DE-Juel1)131627  |b 1  |u fzj 
700 1 |a Filss, Christian  |0 P:(DE-Juel1)141877  |b 2 
700 1 |a Galldiks, Norbert  |0 P:(DE-Juel1)143792  |b 3 
700 1 |a Slotty, Philipp  |0 P:(DE-HGF)0  |b 4 
700 1 |a Kamp, Marcel  |0 P:(DE-HGF)0  |b 5 
700 1 |a el Khatib, Mustafa  |0 P:(DE-HGF)0  |b 6 
700 1 |a Hänggi, Daniel  |0 P:(DE-HGF)0  |b 7 
700 1 |a Sabel, Michael  |0 P:(DE-HGF)0  |b 8 
700 1 |a Felsberg, Jörg  |0 P:(DE-HGF)0  |b 9 
700 1 |a Steiger, Hans Jakob  |0 P:(DE-HGF)0  |b 10 
700 1 |a Coenen, Heinrich Hubert  |0 P:(DE-Juel1)131816  |b 11 
700 1 |a Shah, Nadim J.  |0 P:(DE-Juel1)131794  |b 12 
700 1 |a Langen, Karl-Josef  |0 P:(DE-Juel1)131777  |b 13 
773 |a 10.1007/s00259-014-2934-0  |0 PERI:(DE-600)2098375-X  |n 3  |p 459-467  |t European journal of nuclear medicine and molecular imaging  |v 42  |y 2015  |x 1619-7089 
856 4 |u http://juser.fz-juelich.de/record/171800/files/art_10.1007_s00259-014-2934-0.pdf  |y Restricted 
856 4 |u http://juser.fz-juelich.de/record/171800/files/art_10.1007_s00259-014-2934-0.pdf?subformat=pdfa  |x pdfa  |y Restricted 
909 C O |o oai:juser.fz-juelich.de:171800  |p VDB 
910 1 |a Forschungszentrum Jülich GmbH  |0 I:(DE-588b)5008462-8  |k FZJ  |b 1  |6 P:(DE-Juel1)131627 
910 1 |a Forschungszentrum Jülich GmbH  |0 I:(DE-588b)5008462-8  |k FZJ  |b 2  |6 P:(DE-Juel1)141877 
910 1 |a Forschungszentrum Jülich GmbH  |0 I:(DE-588b)5008462-8  |k FZJ  |b 3  |6 P:(DE-Juel1)143792 
910 1 |a Forschungszentrum Jülich GmbH  |0 I:(DE-588b)5008462-8  |k FZJ  |b 11  |6 P:(DE-Juel1)131816 
910 1 |a Forschungszentrum Jülich GmbH  |0 I:(DE-588b)5008462-8  |k FZJ  |b 12  |6 P:(DE-Juel1)131794 
910 1 |a Forschungszentrum Jülich GmbH  |0 I:(DE-588b)5008462-8  |k FZJ  |b 13  |6 P:(DE-Juel1)131777 
913 0 |a DE-HGF  |b Gesundheit  |l Funktion und Dysfunktion des Nervensystems  |1 G:(DE-HGF)POF2-330  |0 G:(DE-HGF)POF2-333  |2 G:(DE-HGF)POF2-300  |v Pathophysiological Mechanisms of Neurological and Psychiatric Diseases  |x 0 
913 1 |a DE-HGF  |b Key Technologies  |l Decoding the Human Brain  |1 G:(DE-HGF)POF3-570  |0 G:(DE-HGF)POF3-572  |2 G:(DE-HGF)POF3-500  |v (Dys-)function and Plasticity  |x 0  |4 G:(DE-HGF)POF  |3 G:(DE-HGF)POF3 
914 1 |y 2015 
915 |a JCR  |0 StatID:(DE-HGF)0100  |2 StatID 
915 |a WoS  |0 StatID:(DE-HGF)0110  |2 StatID  |b Science Citation Index 
915 |a WoS  |0 StatID:(DE-HGF)0111  |2 StatID  |b Science Citation Index Expanded 
915 |a DBCoverage  |0 StatID:(DE-HGF)0150  |2 StatID  |b Web of Science Core Collection 
915 |a DBCoverage  |0 StatID:(DE-HGF)0199  |2 StatID  |b Thomson Reuters Master Journal List 
915 |a DBCoverage  |0 StatID:(DE-HGF)0200  |2 StatID  |b SCOPUS 
915 |a DBCoverage  |0 StatID:(DE-HGF)0300  |2 StatID  |b Medline 
915 |a DBCoverage  |0 StatID:(DE-HGF)0310  |2 StatID  |b NCBI Molecular Biology Database 
915 |a DBCoverage  |0 StatID:(DE-HGF)1030  |2 StatID  |b Current Contents - Life Sciences 
915 |a DBCoverage  |0 StatID:(DE-HGF)1110  |2 StatID  |b Current Contents - Clinical Medicine 
980 |a journal 
980 |a VDB 
980 |a I:(DE-Juel1)INM-3-20090406 
980 |a I:(DE-Juel1)INM-4-20090406 
980 |a I:(DE-Juel1)INM-5-20090406 
980 |a UNRESTRICTED 
536 |a (Dys-)function and Plasticity  |0 G:(DE-HGF)POF3-572  |c POF3-572  |x 0  |f POF III 
336 |a ARTICLE  |2 BibTeX 
336 |a Nanopartikel unedler Metalle (Mg0, Al0, Gd0, Sm0)  |0 0  |2 EndNote 
336 |a Output Types/Journal article  |2 DataCite 
336 |a Journal Article  |b journal  |m journal  |0 PUB:(DE-HGF)16  |s 1427449921_8798  |2 PUB:(DE-HGF) 
336 |a article  |2 DRIVER 
336 |a JOURNAL_ARTICLE  |2 ORCID 
981 |a I:(DE-Juel1)INM-4-20090406 
920 |k Kognitive Neurowissenschaften; INM-3  |0 I:(DE-Juel1)INM-3-20090406  |l Kognitive Neurowissenschaften  |x 0 
920 |k Nuklearchemie; INM-5  |0 I:(DE-Juel1)INM-5-20090406  |l Nuklearchemie  |x 2 
981 |a I:(DE-Juel1)INM-5-20090406 
920 |k Physik der Medizinischen Bildgebung; INM-4  |0 I:(DE-Juel1)INM-4-20090406  |l Physik der Medizinischen Bildgebung  |x 1 
991 |a Felsberg, Jörg  |0 P:(DE-HGF)0  |b 9 
991 |a Sabel, Michael  |0 P:(DE-HGF)0  |b 8 
991 |a Langen, Karl-Josef  |0 P:(DE-Juel1)131777  |b 13 
991 |a Hänggi, Daniel  |0 P:(DE-HGF)0  |b 7 
991 |a Shah, N. J.  |0 P:(DE-Juel1)131794  |b 12 
991 |a el Khatib, Mustafa  |0 P:(DE-HGF)0  |b 6 
990 |a Cornelius, Jan F.  |0 P:(DE-HGF)0  |b 0  |e Corresponding Author 
991 |a Coenen, Heinrich Hubert  |0 P:(DE-Juel1)131816  |b 11 
991 |a Kamp, Marcel  |0 P:(DE-HGF)0  |b 5 
991 |a Steiger, Hans Jakob  |0 P:(DE-HGF)0  |b 10 
991 |a Slotty, Philipp  |0 P:(DE-HGF)0  |b 4 
991 |a Galldiks, Norbert  |0 P:(DE-Juel1)143792  |b 3 
991 |a Filss, Christian  |0 P:(DE-Juel1)141877  |b 2 
991 |a Stoffels, Gabriele  |0 P:(DE-Juel1)131627  |b 1  |u fzj 

  • Forschungszentrum Jülich
  • Central Library (ZB)
  • Powered by VuFind 6.1.1
Loading...